# Safety and Feasibility of an Endoluminal-suturing Device (Endomina TM) for Gastric Reduction

> **NCT02534662** · NA · COMPLETED · sponsor: **Theodor Bilharz Research Institute** · enrollment: 11 (actual)

## Conditions studied

- Obesity

## Interventions

- **DEVICE:** ENDOMINA

## Key facts

- **NCT ID:** NCT02534662
- **Lead sponsor:** Theodor Bilharz Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2021-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02534662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02534662, "Safety and Feasibility of an Endoluminal-suturing Device (Endomina TM) for Gastric Reduction". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02534662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*